PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTegaderm
Tegaderm
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
112 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—21—2913
Communicable diseasesD003141——11—258
PainD010146EFO_0003843R52—3—216
Wounds and injuriesD014947—T14.8111136
UlcerD014456MPATH_579——1—135
Postoperative painD010149—G89.18———224
CarcinomaD002277—C80.02——114
Diabetic footD017719EFO_1001459——1—124
Foot ulcerD016523———1—124
Catheter-related infectionsD055499—————134
Show 16 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Obstetric labor complicationsD007744————1——1
Surgical wound dehiscenceD013529—T81.31——1——1
AnalgesiaD000698————1——1
AgnosiaD000377HP_0030222F88——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wound infectionD014946——11——45
Surgical wound infectionD013530——11——34
Surgical woundD000072836——11——34
OsteoarthritisD010003EFO_0002506M15-M19—1——23
Breast neoplasmsD001943EFO_0003869C50—1——23
HypertensionD006973EFO_0000537I10—1———1
Pulmonary hypertensionD006976EFO_0001361I27.20—1———1
Pulmonary arterial hypertensionD000081029———1———1
Cutaneous leishmaniasisD016773—B55.1—1———1
LeishmaniasisD007896EFO_0005044B55—1———1
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Squamous cell carcinomaD002294——1———12
Bowen's diseaseD001913—D00-D092————2
CicatrixD002921HP_0100699L90.51———12
Healthy volunteers/patients———1————1
CheilitisD002613HP_0100825K13.01————1
Actinic keratosisD055623—L57.01————1
KeratosisD007642——1————1
Basal cell neoplasmsD018295——1————1
Herpes simplexD006561—B001————1
Herpes labialisD006560EFO_1001347B00.11————1
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PruritusD011537HP_0000989L29————33
Coronary artery diseaseD003324—I25.1————33
CathetersD057785——————33
Nerve blockD009407——————22
Acute painD059787—R52————22
Pressure ulcerD003668——————22
SepsisD018805HP_0100806A41.9————22
Cardiovascular diseasesD002318HP_0001626—————22
AtherosclerosisD050197EFO_0003914I25.1————22
HematomaD006406EFO_0010680—————22
Show 64 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use